NASDAQ:LPNT - LifePoint Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$64.99 0.00 (0.00 %)
(As of 12/16/2018 04:15 AM ET)
Previous Close$64.99
Today's Range$64.99 - $64.99
52-Week Range$41.45 - $65.35
VolumeN/A
Average Volume538,571 shs
Market Capitalization$2.52 billion
P/E Ratio17.90
Dividend YieldN/A
Beta0.51
LifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery. The company's hospitals also offer outpatient services comprising same-day surgery, laboratory, X-ray, respiratory therapy, imaging, sports medicine, and lithotripsy. In addition, it owns and operates schools of nursing and other allied health professions. As of December 31, 2017, the company operated 71 hospital campuses with a total of 9,254 licensed beds in 22 states. The company was formerly known as LifePoint Hospitals, Inc. and changed its name to LifePoint Health, Inc. in May 2015. LifePoint Health, Inc. was founded in 1997 and is based in Brentwood, Tennessee.

Receive LPNT News and Ratings via Email

Sign-up to receive the latest news and ratings for LPNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
Current SymbolNASDAQ:LPNT
Previous Symbol
CUSIP53219L10
Phone615-920-7000

Debt

Debt-to-Equity Ratio1.22
Current Ratio1.85
Quick Ratio1.63

Price-To-Earnings

Trailing P/E Ratio17.90
Forward P/E Ratio14.01
P/E Growth1.73

Sales & Book Value

Annual Sales$7.26 billion
Price / Sales0.35
Cash Flow$12.6686 per share
Price / Cash Flow5.13
Book Value$60.30 per share
Price / Book1.08

Profitability

EPS (Most Recent Fiscal Year)$3.63
Net Income$102.40 million
Net Margins0.59%
Return on Equity7.80%
Return on Assets2.86%

Miscellaneous

Employees42,000
Outstanding Shares38,750,000
Market Cap$2.52 billion
OptionableOptionable

LifePoint Health (NASDAQ:LPNT) Frequently Asked Questions

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How will LifePoint Health's stock buyback program work?

LifePoint Health declared that its board has initiated a stock buyback program on Friday, October 27th 2017, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its stock is undervalued.

How were LifePoint Health's earnings last quarter?

LifePoint Health Inc (NASDAQ:LPNT) announced its quarterly earnings data on Friday, October, 26th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.99 by $0.25. The firm had revenue of $1.56 billion for the quarter, compared to analysts' expectations of $1.55 billion. LifePoint Health had a net margin of 0.59% and a return on equity of 7.80%. The company's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.80 earnings per share. View LifePoint Health's Earnings History.

When is LifePoint Health's next earnings date?

LifePoint Health is scheduled to release their next quarterly earnings announcement on Friday, February 22nd 2019. View Earnings Estimates for LifePoint Health.

What price target have analysts set for LPNT?

14 Wall Street analysts have issued 1 year price targets for LifePoint Health's shares. Their predictions range from $45.00 to $74.00. On average, they anticipate LifePoint Health's share price to reach $58.3333 in the next twelve months. This suggests that the stock has a possible downside of 10.2%. View Analyst Price Targets for LifePoint Health.

What is the consensus analysts' recommendation for LifePoint Health?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifePoint Health in the last year. There are currently 1 sell rating, 12 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for LifePoint Health.

What are Wall Street analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:
  • 1. According to Zacks Investment Research, "LifePoint Health, Inc.’s shares have outperformed its industry’s growth in the past six months. Moreover, the company has witnessed its 2018 earnings estimates move upward over the past seven days. It is in the process of being merged with RCCH HealthCare Partners, which would add scale and size to the business. Its acquisition pipeline remains strong with several opportunities in hospitals, health systems and end-market transactions for expansion of its key services. Nevertheless, the company is suffering from low patient admissions which remains a headwind. A pullback of insurers from public exchanges has increased the uninsured rate, which is hurting the company. Its admissions are likely to remain under pressure as it continues to divest its hospitals. Escalating expenses is another concern for the company." (10/23/2018)
  • 2. Cantor Fitzgerald analysts commented, "LPNT reported in-line 4Q17 results, with revenue that is short of the FactSet consensus but adjusted EBITDA that was in-line. The company has, however, increased its provision for bad debt, and includes the new, more accurate estimate as an adjustment." (2/23/2018)

Has LifePoint Health been receiving favorable news coverage?

News stories about LPNT stock have been trending negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. LifePoint Health earned a coverage optimism score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.

Who are some of LifePoint Health's key competitors?

Who are LifePoint Health's key executives?

LifePoint Health's management team includes the folowing people:
  • Mr. William F. Carpenter III, Chairman & CEO (Age 63)
  • Mr. David M. Dill, Pres & COO (Age 49)
  • Mr. Michael S. Coggin, Exec. VP & CFO (Age 48)
  • Mr. John P. Bumpus, Exec. VP & Chief Admin. Officer (Age 57)
  • John Michael Grooms, VP and Chief Accounting Officer (Age 40)

Who are LifePoint Health's major shareholders?

LifePoint Health's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.35%), Vanguard Group Inc. (8.89%), Vanguard Group Inc (8.89%), Dimensional Fund Advisors LP (8.44%), Alliancebernstein L.P. (4.36%) and LSV Asset Management (3.69%). Company insiders that own LifePoint Health stock include David M Dill, John P Bumpus, Marguerite Kondracke, Richard H Evans and William F Carpenter III. View Institutional Ownership Trends for LifePoint Health.

Which institutional investors are selling LifePoint Health stock?

LPNT stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., LSV Asset Management, Prudential Financial Inc., First Trust Advisors LP, Elk Creek Partners LLC, SG Americas Securities LLC, BlackRock Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for LifePoint Health.

Which institutional investors are buying LifePoint Health stock?

LPNT stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Water Island Capital LLC, Alpine Associates Management Inc., Gabelli Funds LLC, Allianz Asset Management GmbH, Morgan Stanley, Deutsche Bank AG and Gamco Investors INC. ET AL. View Insider Buying and Selling for LifePoint Health.

How do I buy shares of LifePoint Health?

Shares of LPNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LifePoint Health's stock price today?

One share of LPNT stock can currently be purchased for approximately $64.99.

How big of a company is LifePoint Health?

LifePoint Health has a market capitalization of $2.52 billion and generates $7.26 billion in revenue each year. The company earns $102.40 million in net income (profit) each year or $3.63 on an earnings per share basis. LifePoint Health employs 42,000 workers across the globe.

What is LifePoint Health's official website?

The official website for LifePoint Health is http://www.lifepointhealth.net.

How can I contact LifePoint Health?

LifePoint Health's mailing address is 330 Seven Springs Way, Brentwood TN, 37027. The company can be reached via phone at 615-920-7000 or via email at [email protected]


MarketBeat Community Rating for LifePoint Health (NASDAQ LPNT)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  338 (Vote Outperform)
Underperform Votes:  544 (Vote Underperform)
Total Votes:  882
MarketBeat's community ratings are surveys of what our community members think about LifePoint Health and other stocks. Vote "Outperform" if you believe LPNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LPNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Featured Article: Earnings Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel